(lp0
S'Curis, Inc.  Upgraded by Zacks Investment Research to Hold Chaffey Breeze - Mar 15, 2017 Curis logo Curis, Inc.  was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report issued on Tuesday.Curis, Inc.  Upgraded to Hold at Zacks Investment Research - The Cerbat GemThe Curis, Inc.  Releases Quarterly Earnings Results, Beats Expectations ... - Petro Global News 24'
p1
aS'Curis, Inc.  Could Reverse On Near Term Catalysts Insider Financial - Jul 22, 2016 Massachusetts based biotech Curis, Inc.  soared into the close of 2015, as data from its lead oncology candidate hinted at a revolution in cancer therapy.'
p2
aS'Stock Update : Curis, Inc. and Aurigene Extend Exclusivity Period ... Smarter Analyst - Jan 9, 2017 Curis, Inc.  announced that it has exercised its option to extend the exclusivity period with Aurigene under the collaboration, license and option agreement established in January, 2015.'
p3
aS'Curis Inc.  Soars 20.78% on March 09 Equities.com - Mar 9, 2017 Curis Inc.  had a good day on the market for Thursday March 09 as shares jumped 20.78% to close at $3.08. About 3.15 million shares traded hands on 10,696 trades for the day, compared with an average daily volume of 549,567 shares out of a total&nbsp;...Curis, Inc.  Files An 8-K Results of Operations and Financial ... - Market Exclusive'
p4
aS'Curis, Inc.  Trading Up -5.8% Following Better-Than-Expected Earnings BNB Daily  - Mar 12, 2017 Curis logo Curis, Inc.  shot up 5.8% on Friday following a better than expected earnings announcement. The company traded as high as $3.09 and last traded at $2.90, with a volume of 1,821,010 shares.The Dynamic Technology Lab Private Ltd Buys New Position in Curis, Inc.  - Petro Global News 24Curis, Inc.  Posts Earnings Results, Beats Expectations By $0.02 EPS - Chaffey Breeze'
p5
aS'Company Update : Aurigene to Invest in Curis, Inc. at Premium ... Smarter Analyst - Sep 7, 2016 CRIS2 Curis, Inc. , a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of cancer, today announced that its collaborator, Aurigene Discovery Technologies&nbsp;...'
p6
aS'Curis Inc.  Moves Lower on Volume Spike for February 24 Equities.com - Feb 24, 2017 Curis Inc.  traded on unusually high volume on Feb. 24, as the stock lost 1.66% to close at $2.37. On the day, Curis Inc. saw 666,810 shares trade hands on 3,379 trades. Considering that the stock averages only a daily volume of 411,768 shares a ...Curis, Inc.  to Release Earnings on Monday - Chaffey BreezeCuris, Inc.  Set to Announce Earnings on Monday - BBNS'
p7
aS"Curis Inc  Pulls in Gains For the Week Business Review - 16 hours ago Curis Inc  shares have seen strong upward momentum over the past week as they have moved higher 18.11% over the past five sessions, placing them on this week's winners list."
p8
aS'Curis Announces Appointment of Lori A. Kunkel, MD to Board of Directors GlobeNewswire  - Nov 14, 2016 LEXINGTON, Mass., Nov. 14, 2016  -- Curis, Inc. , a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers, today&nbsp;...'
p9
aS'Curis Inc Realized Volatility Hits An Escalated Level CML News - Feb 7, 2017 This is a proprietary realized volatility rating created by Capital Market Laboratories  based on a large number of data interactions for Curis Inc  . We examine the little used gem of daily stock volatility over a 20-day and 30 ...'
p10
a.